AGP Picks
View all

STEM Wire Oklahoma
Provided by AGP

STEM Wire Oklahoma: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Wire Oklahoma.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 4, 2026

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Jun. 4, 2026

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

Indeterminate GlobeNewswire
Diginex Expands Supply Chain End-to-End Product Suite Amid Accelerating Regulatory Pressure
Jun. 4, 2026

Diginex Expands Supply Chain End-to-End Product Suite Amid Accelerating Regulatory Pressure

Indeterminate GlobeNewswire
BIO-key’s RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ET
Jun. 4, 2026

BIO-key’s RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ET

Indeterminate GlobeNewswire
Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans
Jun. 4, 2026

Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans

Indeterminate GlobeNewswire
SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum
Jun. 4, 2026

SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum

Indeterminate GlobeNewswire
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution
Jun. 4, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution

Indeterminate GlobeNewswire
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
Jun. 4, 2026

Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory

Indeterminate GlobeNewswire
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Jun. 4, 2026

Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy

Indeterminate GlobeNewswire
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
Jun. 4, 2026

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

Indeterminate GlobeNewswire
OT Group Ltd Provides Monthly Market Update and Private Equity Outlook
Jun. 4, 2026

OT Group Ltd Provides Monthly Market Update and Private Equity Outlook

Indeterminate GlobeNewswire
Microchip Technology Receives U.S. Export License to Expand Advanced FPGA Development in Armenia
Jun. 4, 2026

Microchip Technology Receives U.S. Export License to Expand Advanced FPGA Development in Armenia

Indeterminate GlobeNewswire
Global-e Announces Board Authorization of $500 Million Share Repurchase Program
Jun. 4, 2026

Global-e Announces Board Authorization of $500 Million Share Repurchase Program

Indeterminate GlobeNewswire
The Catalyst/Millburn Hedge Strategy Fund (MBXIX) Surpasses $10 Billion in Assets Under Management
Jun. 4, 2026

The Catalyst/Millburn Hedge Strategy Fund (MBXIX) Surpasses $10 Billion in Assets Under Management

Indeterminate GlobeNewswire
Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting
Jun. 4, 2026

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

Indeterminate GlobeNewswire
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
Jun. 4, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
Jun. 4, 2026

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Indeterminate GlobeNewswire
Ovid Therapeutics to Participate in Upcoming Investor Conferences
Jun. 4, 2026

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis
Jun. 4, 2026

Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026
Jun. 4, 2026

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire
BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
Jun. 4, 2026

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

STEM Wire Oklahoma

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.